Global Osteoarthritis Pain Drugs Market Professional Survey Report 2018

June 2018 | 119 pages | ID: GB245787D55EN
QYResearch

Abstracts

This report studies the global Osteoarthritis Pain Drugs market status and forecast, categorizes the global Osteoarthritis Pain Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).
The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers:
Painkillers only: Only a simple analgesic effect, but no anti-inflammatory function, such as acetaminophen, tramadol. Acetaminophen side effects, but the analgesic effect is relatively weak, mainly for mild to moderate pain; tramadol analgesic effect is strong, but also side effects are larger, mainly gastrointestinal side effects such as nausea, vomiting and so on.
NSAIDs: With both anti-inflammatory and analgesic effect, suitable for inflammatory pain, for the acute phase of osteoarthritis, joint swelling of the patients to relieve symptoms better. These drugs may lead to nausea, vomiting and other gastrointestinal discomfort, but also increase the risk of gastrointestinal bleeding, so patients with gastro duodenal ulcer in the application of these drugs should consult a digestive physician, plus gastric mucosal protection Drugs or antacid drugs.
Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint.
Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement.
The USA osteoarthritis pain drugs market is very concerted market; the revenue of eleven manufacturers accounts about 88% of the total revenue in 2016. The high-end products mainly come from USA and Europe.
The leading manufactures mainly are Johnson & Johnson, Pfizer and GlaxoSmithKline. Johnson & Johnson is the largest manufacturer; its revenue of USA market exceeds 27% in 2016. The next is Pfizer and GlaxoSmithKline.

The global Osteoarthritis Pain Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report

• Johnson & Johnson
• Pfizer
• GlaxoSmithKline
• Mylan
• Lilly
• Sanofi
• Abbott Laboratories
• Bayer
• Almatica Pharma
• TEVA
• Iroko Pharmaceuticals

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

• North America
• Europe
• China
• Japan
• India
• Southeast Asia
• Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Oral
• Injection
• External

By Application, the market can be split into

• Medical Care
• Personal Care

The study objectives of this report are:

• To analyze and study the global Osteoarthritis Pain Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
• Focuses on the key Osteoarthritis Pain Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Osteoarthritis Pain Drugs are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Osteoarthritis Pain Drugs Manufacturers
Osteoarthritis Pain Drugs Distributors/Traders/Wholesalers
Osteoarthritis Pain Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations

• With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
• Regional and country-level analysis of the Osteoarthritis Pain Drugs market, by end-use.
• Detailed analysis and profiles of additional market players.

Contents

Global Osteoarthritis Pain Drugs Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF OSTEOARTHRITIS PAIN DRUGS

1.1 Definition and Specifications of Osteoarthritis Pain Drugs
  1.1.1 Definition of Osteoarthritis Pain Drugs
  1.1.2 Specifications of Osteoarthritis Pain Drugs
1.2 Classification of Osteoarthritis Pain Drugs
  1.2.1 Oral
  1.2.2 Injection
  1.2.3 External
1.3 Applications of Osteoarthritis Pain Drugs
  1.3.1 Medical Care
  1.3.2 Personal Care
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 Europe
  1.4.3 China
  1.4.4 Japan
  1.4.5 Southeast Asia
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF OSTEOARTHRITIS PAIN DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Osteoarthritis Pain Drugs
2.3 Manufacturing Process Analysis of Osteoarthritis Pain Drugs
2.4 Industry Chain Structure of Osteoarthritis Pain Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF OSTEOARTHRITIS PAIN DRUGS

3.1 Capacity and Commercial Production Date of Global Osteoarthritis Pain Drugs Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Osteoarthritis Pain Drugs Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Osteoarthritis Pain Drugs Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Osteoarthritis Pain Drugs Major Manufacturers in 2017

4 GLOBAL OSTEOARTHRITIS PAIN DRUGS OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Osteoarthritis Pain Drugs Capacity and Growth Rate Analysis
  4.2.2 2017 Osteoarthritis Pain Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Osteoarthritis Pain Drugs Sales and Growth Rate Analysis
  4.3.2 2017 Osteoarthritis Pain Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Osteoarthritis Pain Drugs Sales Price
  4.4.2 2017 Osteoarthritis Pain Drugs Sales Price Analysis (Company Segment)

5 OSTEOARTHRITIS PAIN DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Osteoarthritis Pain Drugs Market Analysis
  5.1.1 North America Osteoarthritis Pain Drugs Market Overview
  5.1.2 North America 2013-2018E Osteoarthritis Pain Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Osteoarthritis Pain Drugs Sales Price Analysis
  5.1.4 North America 2017 Osteoarthritis Pain Drugs Market Share Analysis
5.2 Europe Osteoarthritis Pain Drugs Market Analysis
  5.2.1 Europe Osteoarthritis Pain Drugs Market Overview
  5.2.2 Europe 2013-2018E Osteoarthritis Pain Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2013-2018E Osteoarthritis Pain Drugs Sales Price Analysis
  5.2.4 Europe 2017 Osteoarthritis Pain Drugs Market Share Analysis
5.3 China Osteoarthritis Pain Drugs Market Analysis
  5.3.1 China Osteoarthritis Pain Drugs Market Overview
  5.3.2 China 2013-2018E Osteoarthritis Pain Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2013-2018E Osteoarthritis Pain Drugs Sales Price Analysis
  5.3.4 China 2017 Osteoarthritis Pain Drugs Market Share Analysis
5.4 Japan Osteoarthritis Pain Drugs Market Analysis
  5.4.1 Japan Osteoarthritis Pain Drugs Market Overview
  5.4.2 Japan 2013-2018E Osteoarthritis Pain Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2013-2018E Osteoarthritis Pain Drugs Sales Price Analysis
  5.4.4 Japan 2017 Osteoarthritis Pain Drugs Market Share Analysis
5.5 Southeast Asia Osteoarthritis Pain Drugs Market Analysis
  5.5.1 Southeast Asia Osteoarthritis Pain Drugs Market Overview
  5.5.2 Southeast Asia 2013-2018E Osteoarthritis Pain Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2013-2018E Osteoarthritis Pain Drugs Sales Price Analysis
  5.5.4 Southeast Asia 2017 Osteoarthritis Pain Drugs Market Share Analysis
5.6 India Osteoarthritis Pain Drugs Market Analysis
  5.6.1 India Osteoarthritis Pain Drugs Market Overview
  5.6.2 India 2013-2018E Osteoarthritis Pain Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Osteoarthritis Pain Drugs Sales Price Analysis
  5.6.4 India 2017 Osteoarthritis Pain Drugs Market Share Analysis

6 GLOBAL 2013-2018E OSTEOARTHRITIS PAIN DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Osteoarthritis Pain Drugs Sales by Type
6.2 Different Types of Osteoarthritis Pain Drugs Product Interview Price Analysis
6.3 Different Types of Osteoarthritis Pain Drugs Product Driving Factors Analysis
  6.3.1 Oral Growth Driving Factor Analysis
  6.3.2 Injection Growth Driving Factor Analysis
  6.3.3 External Growth Driving Factor Analysis

7 GLOBAL 2013-2018E OSTEOARTHRITIS PAIN DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Osteoarthritis Pain Drugs Consumption by Application
7.2 Different Application of Osteoarthritis Pain Drugs Product Interview Price Analysis
7.3 Different Application of Osteoarthritis Pain Drugs Product Driving Factors Analysis
  7.3.1 Medical Care of Osteoarthritis Pain Drugs Growth Driving Factor Analysis
  7.3.2 Personal Care of Osteoarthritis Pain Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF OSTEOARTHRITIS PAIN DRUGS

8.1 Johnson & Johnson
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Johnson & Johnson 2017 Osteoarthritis Pain Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Johnson & Johnson 2017 Osteoarthritis Pain Drugs Business Region Distribution Analysis
8.2 Pfizer
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Pfizer 2017 Osteoarthritis Pain Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Pfizer 2017 Osteoarthritis Pain Drugs Business Region Distribution Analysis
8.3 GlaxoSmithKline
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 GlaxoSmithKline 2017 Osteoarthritis Pain Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 GlaxoSmithKline 2017 Osteoarthritis Pain Drugs Business Region Distribution Analysis
8.4 Mylan
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Mylan 2017 Osteoarthritis Pain Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Mylan 2017 Osteoarthritis Pain Drugs Business Region Distribution Analysis
8.5 Lilly
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Lilly 2017 Osteoarthritis Pain Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Lilly 2017 Osteoarthritis Pain Drugs Business Region Distribution Analysis
8.6 Sanofi
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Sanofi 2017 Osteoarthritis Pain Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Sanofi 2017 Osteoarthritis Pain Drugs Business Region Distribution Analysis
8.7 Abbott Laboratories
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Abbott Laboratories 2017 Osteoarthritis Pain Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Abbott Laboratories 2017 Osteoarthritis Pain Drugs Business Region Distribution Analysis
8.8 Bayer
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Bayer 2017 Osteoarthritis Pain Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Bayer 2017 Osteoarthritis Pain Drugs Business Region Distribution Analysis
8.9 Almatica Pharma
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Almatica Pharma 2017 Osteoarthritis Pain Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Almatica Pharma 2017 Osteoarthritis Pain Drugs Business Region Distribution Analysis
8.10 TEVA
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 TEVA 2017 Osteoarthritis Pain Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 TEVA 2017 Osteoarthritis Pain Drugs Business Region Distribution Analysis
8.11 Iroko Pharmaceuticals

9 DEVELOPMENT TREND OF ANALYSIS OF OSTEOARTHRITIS PAIN DRUGS MARKET

9.1 Global Osteoarthritis Pain Drugs Market Trend Analysis
  9.1.1 Global 2018-2025 Osteoarthritis Pain Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Osteoarthritis Pain Drugs Sales Price Forecast
9.2 Osteoarthritis Pain Drugs Regional Market Trend
  9.2.1 North America 2018-2025 Osteoarthritis Pain Drugs Consumption Forecast
  9.2.2 Europe 2018-2025 Osteoarthritis Pain Drugs Consumption Forecast
  9.2.3 China 2018-2025 Osteoarthritis Pain Drugs Consumption Forecast
  9.2.4 Japan 2018-2025 Osteoarthritis Pain Drugs Consumption Forecast
  9.2.5 Southeast Asia 2018-2025 Osteoarthritis Pain Drugs Consumption Forecast
  9.2.6 India 2018-2025 Osteoarthritis Pain Drugs Consumption Forecast
9.3 Osteoarthritis Pain Drugs Market Trend (Product Type)
9.4 Osteoarthritis Pain Drugs Market Trend (Application)

10 OSTEOARTHRITIS PAIN DRUGS MARKETING TYPE ANALYSIS

10.1 Osteoarthritis Pain Drugs Regional Marketing Type Analysis
10.2 Osteoarthritis Pain Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Osteoarthritis Pain Drugs by Region
10.4 Osteoarthritis Pain Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF OSTEOARTHRITIS PAIN DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL OSTEOARTHRITIS PAIN DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Osteoarthritis Pain Drugs
Table Product Specifications of Osteoarthritis Pain Drugs
Table Classification of Osteoarthritis Pain Drugs
Figure Global Production Market Share of Osteoarthritis Pain Drugs by Type in 2017
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Injection Picture
Table Major Manufacturers of Injection
Figure External Picture
Table Major Manufacturers of External
Table Applications of Osteoarthritis Pain Drugs
Figure Global Consumption Volume Market Share of Osteoarthritis Pain Drugs by Application in 2017
Figure Medical Care Examples
Table Major Consumers in Medical Care
Figure Personal Care Examples
Table Major Consumers in Personal Care
Figure Market Share of Osteoarthritis Pain Drugs by Regions
Figure North America Osteoarthritis Pain Drugs Market Size (Million USD) (2013-2025)
Figure Europe Osteoarthritis Pain Drugs Market Size (Million USD) (2013-2025)
Figure China Osteoarthritis Pain Drugs Market Size (Million USD) (2013-2025)
Figure Japan Osteoarthritis Pain Drugs Market Size (Million USD) (2013-2025)
Figure Southeast Asia Osteoarthritis Pain Drugs Market Size (Million USD) (2013-2025)
Figure India Osteoarthritis Pain Drugs Market Size (Million USD) (2013-2025)
Table Osteoarthritis Pain Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Osteoarthritis Pain Drugs in 2017
Figure Manufacturing Process Analysis of Osteoarthritis Pain Drugs
Figure Industry Chain Structure of Osteoarthritis Pain Drugs
Table Capacity and Commercial Production Date of Global Osteoarthritis Pain Drugs Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Osteoarthritis Pain Drugs Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Osteoarthritis Pain Drugs Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Osteoarthritis Pain Drugs Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Osteoarthritis Pain Drugs 2013-2018E
Figure Global 2013-2018E Osteoarthritis Pain Drugs Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Osteoarthritis Pain Drugs Market Size (Value) and Growth Rate
Table 2013-2018E Global Osteoarthritis Pain Drugs Capacity and Growth Rate
Table 2017 Global Osteoarthritis Pain Drugs Capacity (M Dose) List (Company Segment)
Table 2013-2018E Global Osteoarthritis Pain Drugs Sales (M Dose) and Growth Rate
Table 2017 Global Osteoarthritis Pain Drugs Sales (M Dose) List (Company Segment)
Table 2013-2018E Global Osteoarthritis Pain Drugs Sales Price (USD/K Dose)
Table 2017 Global Osteoarthritis Pain Drugs Sales Price (USD/K Dose) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (M Dose) of Osteoarthritis Pain Drugs 2013-2018E
Figure North America 2013-2018E Osteoarthritis Pain Drugs Sales Price (USD/K Dose)
Figure North America 2017 Osteoarthritis Pain Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (M Dose) of Osteoarthritis Pain Drugs 2013-2018E
Figure Europe 2013-2018E Osteoarthritis Pain Drugs Sales Price (USD/K Dose)
Figure Europe 2017 Osteoarthritis Pain Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (M Dose) of Osteoarthritis Pain Drugs 2013-2018E
Figure China 2013-2018E Osteoarthritis Pain Drugs Sales Price (USD/K Dose)
Figure China 2017 Osteoarthritis Pain Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (M Dose) of Osteoarthritis Pain Drugs 2013-2018E
Figure Japan 2013-2018E Osteoarthritis Pain Drugs Sales Price (USD/K Dose)
Figure Japan 2017 Osteoarthritis Pain Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (M Dose) of Osteoarthritis Pain Drugs 2013-2018E
Figure Southeast Asia 2013-2018E Osteoarthritis Pain Drugs Sales Price (USD/K Dose)
Figure Southeast Asia 2017 Osteoarthritis Pain Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (M Dose) of Osteoarthritis Pain Drugs 2013-2018E
Figure India 2013-2018E Osteoarthritis Pain Drugs Sales Price (USD/K Dose)
Figure India 2017 Osteoarthritis Pain Drugs Sales Market Share
Table Global 2013-2018E Osteoarthritis Pain Drugs Sales (M Dose) by Type
Table Different Types Osteoarthritis Pain Drugs Product Interview Price
Table Global 2013-2018E Osteoarthritis Pain Drugs Sales (M Dose) by Application
Table Different Application Osteoarthritis Pain Drugs Product Interview Price
Table Johnson & Johnson Information List
Table Product Overview
Table 2017 Johnson & Johnson Osteoarthritis Pain Drugs Revenue (Million USD), Sales (M Dose), Ex-factory Price (USD/K Dose)
Figure 2017 Johnson & Johnson Osteoarthritis Pain Drugs Business Region Distribution
Table Pfizer Information List
Table Product Overview
Table 2017 Pfizer Osteoarthritis Pain Drugs Revenue (Million USD), Sales (M Dose), Ex-factory Price (USD/K Dose)
Figure 2017 Pfizer Osteoarthritis Pain Drugs Business Region Distribution
Table GlaxoSmithKline Information List
Table Product Overview
Table 2017 GlaxoSmithKline Osteoarthritis Pain Drugs Revenue (Million USD), Sales (M Dose), Ex-factory Price (USD/K Dose)
Figure 2017 GlaxoSmithKline Osteoarthritis Pain Drugs Business Region Distribution
Table Mylan Information List
Table Product Overview
Table 2017 Mylan Osteoarthritis Pain Drugs Revenue (Million USD), Sales (M Dose), Ex-factory Price (USD/K Dose)
Figure 2017 Mylan Osteoarthritis Pain Drugs Business Region Distribution
Table Lilly Information List
Table Product Overview
Table 2017 Lilly Osteoarthritis Pain Drugs Revenue (Million USD), Sales (M Dose), Ex-factory Price (USD/K Dose)
Figure 2017 Lilly Osteoarthritis Pain Drugs Business Region Distribution
Table Sanofi Information List
Table Product Overview
Table 2017 Sanofi Osteoarthritis Pain Drugs Revenue (Million USD), Sales (M Dose), Ex-factory Price (USD/K Dose)
Figure 2017 Sanofi Osteoarthritis Pain Drugs Business Region Distribution
Table Abbott Laboratories Information List
Table Product Overview
Table 2017 Abbott Laboratories Osteoarthritis Pain Drugs Revenue (Million USD), Sales (M Dose), Ex-factory Price (USD/K Dose)
Figure 2017 Abbott Laboratories Osteoarthritis Pain Drugs Business Region Distribution
Table Bayer Information List
Table Product Overview
Table 2017 Bayer Osteoarthritis Pain Drugs Revenue (Million USD), Sales (M Dose), Ex-factory Price (USD/K Dose)
Figure 2017 Bayer Osteoarthritis Pain Drugs Business Region Distribution
Table Almatica Pharma Information List
Table Product Overview
Table 2017 Almatica Pharma Osteoarthritis Pain Drugs Revenue (Million USD), Sales (M Dose), Ex-factory Price (USD/K Dose)
Figure 2017 Almatica Pharma Osteoarthritis Pain Drugs Business Region Distribution
Table TEVA Information List
Table Product Overview
Table 2017 TEVA Osteoarthritis Pain Drugs Revenue (Million USD), Sales (M Dose), Ex-factory Price (USD/K Dose)
Figure 2017 TEVA Osteoarthritis Pain Drugs Business Region Distribution
Table Iroko Pharmaceuticals Information List
Figure Global 2018-2025 Osteoarthritis Pain Drugs Market Size (M Dose) and Growth Rate Forecast
Figure Global 2018-2025 Osteoarthritis Pain Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Osteoarthritis Pain Drugs Sales Price (USD/K Dose) Forecast
Figure North America 2018-2025 Osteoarthritis Pain Drugs Consumption Volume (M Dose) and Growth Rate Forecast
Figure China 2018-2025 Osteoarthritis Pain Drugs Consumption Volume (M Dose) and Growth Rate Forecast
Figure Europe 2018-2025 Osteoarthritis Pain Drugs Consumption Volume (M Dose) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Osteoarthritis Pain Drugs Consumption Volume (M Dose) and Growth Rate Forecast
Figure Japan 2018-2025 Osteoarthritis Pain Drugs Consumption Volume (M Dose) and Growth Rate Forecast
Figure India 2018-2025 Osteoarthritis Pain Drugs Consumption Volume (M Dose) and Growth Rate Forecast
Table Global Sales Volume (M Dose) of Osteoarthritis Pain Drugs by Type 2018-2025
Table Global Consumption Volume (M Dose) of Osteoarthritis Pain Drugs by Application 2018-2025
Table Traders or Distributors with Contact Information of Osteoarthritis Pain Drugs by Region